Current status and prospects for development of an HSV vaccine
about
The challenges and opportunities for the development of a T-cell epitope-based herpes simplex vaccineApproved Antiviral Drugs over the Past 50 YearsGlobal sensing of the antigenic structure of herpes simplex virus gD using high-throughput array-based SPR imaging.Enrichment of herpes simplex virus type 2 (HSV-2) reactive mucosal T cells in the human female genital tract.A single intramuscular vaccination of mice with the HSV-1 VC2 virus with mutations in the glycoprotein K and the membrane protein UL20 confers full protection against lethal intravaginal challenge with virulent HSV-1 and HSV-2 strains.Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humansGlobal estimates of prevalent and incident herpes simplex virus type 2 infections in 2012.Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012.Ionic derivatives of betulinic acid exhibit antiviral activity against herpes simplex virus type-2 (HSV-2), but not HIV-1 reverse transcriptaseHerpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period.Protection from genital herpes disease, seroconversion and latent infection in a non-lethal murine genital infection model by immunization with an HSV-2 replication-defective mutant virus.Current Concepts for Genital Herpes Simplex Virus Infection: Diagnostics and Pathogenesis of Genital Tract SheddingHerpes Simplex Vaccines: Prospects of Live-attenuated HSV Vaccines to Combat Genital and Ocular infections.Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action.Ex vivo 2D and 3D HSV-2 infection model using human normal vaginal epithelial cells.Antigenic breadth: a missing ingredient in HSV-2 subunit vaccines?A novel approach for addressing diseases not yielding to effective vaccination? Immunization by replication-competent controlled virus.Nucleic acid vaccination strategies against infectious diseases.Overexpression and purification of HSV-2 glycoprotein D in suspension CHO cells with serum-free medium and immunogenicity analysis.Highly conserved intragenic HSV-2 sequences: Results from next-generation sequencing of HSV-2 UL and US regions from genital swabs collected from 3 continents.Development of Recombinant HSV-Based Vaccine Vectors.Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.Model-based estimation of superinfection prevalence from limited datasets.Dendrimeric based microbicides against sexual transmitted infections associated to heparan sulfateHSV-2 and Substance Abuse amongst Adolescents: Insights through Mathematical Modelling
P2860
Q27021292-C3E16B8C-6A91-4E5A-B0EA-E413D3CB51D9Q27755387-97174486-8ED9-4DA6-9E10-7D9A424763A3Q33834821-8DDBC5AF-DCE0-41C8-820D-380B093E0F28Q33870372-ED47A1C9-CD98-420D-A0F3-05F62817A7B6Q34414463-188A5422-CCF5-49F4-A99C-CB887AD9CD40Q34593833-BA14F194-65A5-4BE7-A16E-7E352C89CBE1Q34995329-8D87F311-21DC-4B5C-A449-CA7C81184690Q35824550-F9746DDB-4DA2-42E3-81B6-1AFA0941DF0AQ35828340-D55F448E-8F92-41B9-8028-6AE81CCCDEE2Q36092857-382D9B1F-75EA-43B3-8B5B-A59DD3628A76Q36553837-27158EBA-3074-43B9-AD7A-41134F0E553EQ36630996-95D1E3F4-7836-4332-85A5-3AAD32FEDF35Q36824210-25ECE40C-43D7-430C-AA6E-30DE80ACE39FQ36926843-6EC93583-5557-4595-B5CF-CFDFEF146F43Q37716535-D0173502-F30B-4C37-B7EA-8D20A14CADD0Q38212516-F586D38C-9D6C-4464-A693-3C3CF4C806FDQ38353693-964204BC-EA55-4A54-A95F-600BD4E3B094Q38586079-67012BB8-1AC3-4D6B-9BBB-4EF301C19F9EQ38883116-B4CCF41B-9549-45C0-B21A-CE5B52D0ED7BQ40121437-A05EC050-B41B-44D0-9A43-4EC04DDAC492Q40259646-6876DFB6-7121-480B-A1DF-615F135E1F9CQ41928445-AA0BE72A-C03E-4D2C-8CB9-58AC54FD5337Q50533686-1A436FCA-F605-43C4-B3AD-A52E35F27F4BQ57079901-A87F6BB6-57AD-4056-9FE3-87FFF8C6D433Q59049355-8C6DA54E-06BE-4857-984B-B229456CA0E3
P2860
Current status and prospects for development of an HSV vaccine
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Current status and prospects for development of an HSV vaccine
@ast
Current status and prospects for development of an HSV vaccine
@en
type
label
Current status and prospects for development of an HSV vaccine
@ast
Current status and prospects for development of an HSV vaccine
@en
prefLabel
Current status and prospects for development of an HSV vaccine
@ast
Current status and prospects for development of an HSV vaccine
@en
P2860
P50
P1433
P1476
Current status and prospects for development of an HSV vaccine
@en
P2860
P304
P356
10.1016/J.VACCINE.2013.08.066
P407
P577
2013-09-06T00:00:00Z